Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03231241 · ClinicalTrials.gov registry record
Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
A clinical trial of Chronic Migraine and Chronic Daily Headache, sponsored by Stanford University.
- Recruiting
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT03231241 is a study of Chronic Migraine and Chronic Daily Headache that is actively recruiting participants, run by Stanford University. The registered enrollment target is 700 participants, above the 302-participant average among 17 other Chronic Migraine trials with a reported enrollment target (132% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03231241, a study of Chronic Migraine and Chronic Daily Headache, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help explain this process.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2014-12-12 |
| Est. Completion | 2026-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03231241
The ClinicalTrials.gov registry entry for NCT03231241 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 302-participant average among 17 other Chronic Migraine trials with a reported enrollment target (132% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Migraine appearing as the primary indexed condition, and to 0 interventions.
NCT03231241 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03231241 about?
NCT03231241 is a clinical study titled "Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics". Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help ...
What is the current status of trial NCT03231241?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2014-12-12. Estimated completion is 2026-09-01.
What conditions does trial NCT03231241 study?
This clinical trial studies the following conditions: Chronic Migraine, Chronic Daily Headache.
Who is sponsoring clinical trial NCT03231241?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03231241 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BOTOX® vs. XEOMIN® for Chronic Migraine
RECRUITING · Phase 3
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
RECRUITING · NA
-
Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.